MedPath

Establish Diagnostic Models Based on Olfactory Function and Odor-induced Brain Activation for Diabetes-Related Cognitive Impairment

Recruiting
Conditions
Type 2 Diabetes Mellitus
Cognitive Impairment
Registration Number
NCT05543967
Lead Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Brief Summary

This is a cross-sectional and longitudinal study to establish diagnostic models based on olfactory function assessments and odor-induced brain activation for cognitive impairment in patients with type 2 diabetes mellitus.

Detailed Description

Patients with diabetes have increased risks of cognitive impairment and dementia, which affecting the quality of life and diabetes management. Therefore, it is an urgent challenge to identify non-invasive biomarkers for early diagnosis and prognosis of the cognitive decline in patients with diabetes. Previous research has shown that both olfactory dysfunction and decreased odor-induced brain activation are present before clinically measurable cognitive decrements in type 2 diabetes. This is a cross-sectional and longitudinal study to establish diagnostic models based on olfactory function assessments and odor-induced brain activation for cognitive impairment in patients with type 2 diabetes mellitus. The investigators will recruit 200 patients with type 2 diabetes in the outpatient and inpatient departments. Health controls will be recruited from the community. At the baseline, clinical information collection, 100g-steamed bread meal test, biochemical measurement, cognitive assessments, olfactory test and functional magnetic resonance imaging(fMRI) scan will be conducted for all participants. Study duration was 3 years with a follow-up every 18 months. In the longitudinal study, all of the assessments will be repeated to evaluate changes of observational parameters.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Aged 40-75 years
  • Right handedness
  • Possessed over 6-year education
  • Provision of informed consent prior to any study specific procedures
  • Disease duration of T2DM patients >1 year
Exclusion Criteria
  • Control participants would be excluded if they had a fasting blood glucose level >7.0 mmol/L; glucose level> 7.8 mmol/L after oral glucose tolerance test (OGTT); HbA1c>5.7%
  • Control participants would be excluded if they had a Montreal Cognitive Assessment (MoCA, Beijing edition) score of < 26
  • Any acute disease
  • History of neurologic or psychological illness
  • Abnormal results of thyroid hormones, vitamin B12, and folate
  • Metal implants, unable to complete the MR scanning
  • Partial or complete olfactory dysfunction associated with sinusitis, allergic rhinitis, and deviated nasal septum
  • Pregnant or lactating women
  • Participating in other clinical trials at the same time or within 6 months prior to the start of the trial

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Baseline cognitive performanceDay 1 of entry study

The Montreal Cognitive Assessment (MoCA) score, ranges from 0 to 30, and higher scores mean better cognition.

Baseline olfactory thresholdDay 1 of entry study

Olfactory threshold test: score range 1-13.5, which is determined based on a series of binary dilutions of the N-butanol solution in light mineral oil. The higher the score is, the more sensitive the participant is in detecting an odor. Scores of 8-10 were considered normal olfactory sensitivity, whereas scores of 1-3 signified olfactory dysfunction or anosmia, and scores of ≥10 indicate better olfactory sensitivity.

Baseline olfactory memoryDay 1 of entry study

Olfactory memory test: Part A: Participants are shown 4 pictures for each odor (10 odors in total), then they need to select what they sniffed. Have a 10-minute break. Part B: Participants sniff 20 different odors, 10 of which are the same odors as in Part A. They need to select the picture and figure out whether the odor is old or new.

Baseline odor-induced brain fMRI activationWithin 1 week after cognitive assessments

Each participant underwent a series of task fMRI scans to measure temporal brain response to four increasing concentrations of lavender odors (0.032%, 0.10%, 0.32%, and 1.0) diluted in 1,2-propanediol (Sigma-Aldrich, St. Louis, MO). The visual cues of "+" and "smell" were used for baseline and odor stimulation, respectively. Each concentration was assessed three times, with fresh air and scent occurring alternately. Participants were instructed to press a button once they smelled the lavender scent. A general linear model was used to estimate odor-induced brain activation. Contrasts between "fresh air \> rest" and "scent \> rest" for each participant were made to get odor-induced brain activation value. Bilateral parahippocampus, amygdala, piriform cortex, insula, orbitofrontal cortex, entorhinal cortex, and hippocampus were extracted and merged as olfactory regions of interest (ROIs) for further analyses.

Longitudinal changes of cognitive performanceFrom baseline to 18 months' follow-up and 36 months' follow-up

Compare the change of MoCA score from baseline to each follow-up time points (18 months' follow-up, 36 months' follow-up). The Montreal Cognitive Assessment (MoCA) score, ranges from 0 to 30, and higher scores mean better cognition.

Longitudinal changes of olfactory thresholdFrom baseline to 18 months' follow-up and 36 months' follow-up

Compare the change of olfactory threshold tests score from baseline to each follow-up time points (18 months' follow-up, 36 months' follow-up). Olfactory threshold test: score range 1-13.5, which is determined based on a series of binary dilutions of the N-butanol solution in light mineral oil. The higher the score is, the more sensitive the participant is in detecting an odor. Scores of 8-10 were considered normal olfactory sensitivity, whereas scores of 1-3 signified olfactory dysfunction or anosmia, and scores of ≥10 indicate better olfactory sensitivity.

Longitudinal changes of olfactory memoryFrom baseline to 18 months' follow-up and 36 months' follow-up

Compare the change of olfactory memory tests score from baseline to each follow-up time points (18 months' follow-up, 36 months' follow-up). Olfactory memory test: Part A: Participants are shown 4 pictures for each odor (10 odors in total), then they need to select what they sniffed. Have a 10-minute break. Part B: Participants sniff 20 different odors, 10 of which are the same odors as in Part A. They need to select the picture and figure out whether the odor is old or new.

Longitudinal changes of odor-induced brain fMRI activationFrom baseline to 18 months' follow-up and 36 months' follow-up

Compare the change of odor-induced brain activation beta value from baseline to each follow-up time points (18 months' follow-up, 36 months' follow-up)

Secondary Outcome Measures
NameTimeMethod
Baseline brain structural MRI scanWithin 1 week after cognitive assessments

Cortical morphology

Baseline brain functional MRI scanWithin 1 week after cognitive assessments

Large-scale network functional connectivity

Longitudinal changes of brain structural MRI scanFrom baseline to 18 months' follow-up and 36 months' follow-up

Compare the change of cortical morphology from baseline to each follow-up time points (18 months' follow-up, 36 months' follow-up)

Longitudinal changes of functional MRI scanFrom baseline to 18 months' follow-up and 36 months' follow-up

Compare the change of large-scale network functional connectivity from baseline to each follow-up time points (18 months' follow-up, 36 months' follow-up)

Trial Locations

Locations (1)

Department of Radiology, the Affiliated Drum Tower Hospital of Nanjing University

🇨🇳

Nanjing, Jiangsu, China

Department of Radiology, the Affiliated Drum Tower Hospital of Nanjing University
🇨🇳Nanjing, Jiangsu, China
Bing Zhang, MD, PhD
Principal Investigator
Wen Zhang, MD, PhD
Sub Investigator
© Copyright 2025. All Rights Reserved by MedPath